文献速递糖尿病

新发1型和2型糖尿病中炎症生物标志物与肾小球滤过率的关联

Biomarkers of Inflammation and Glomerular Filtration Rate in Individuals with Recent-Onset Type 1 and Type 2 Diabetes.
PubMed 文献 · J Clin Endocrinol Metab · 2020-01-01

本研究基于德国糖尿病研究,纳入病程<1年的1型糖尿病165例和2型糖尿病291例,检测74种炎症相关生物标志物。横断面分析发现,1型糖尿病中7种、2型糖尿病中24种生物标志物与较低基线eGFR相关,其中6种在两种糖尿病中均呈负相关;前瞻性分析未发现炎症生物标志物与5年肾功能下降相关。

要点

  • 新发1型和2型糖尿病中,多种炎症生物标志物与基线eGFR较低相关
  • CD5、CCL23、CST5、IL-10RB、PD-L1、TNFRSF9在两种糖尿病中均与eGFR负相关
  • 炎症生物标志物未显示与诊断后5年内肾功能下降相关

核心结论

  • 在新发1型和2型糖尿病中,多种炎症生物标志物与较低基线eGFR相关,但与诊断后5年内的肾功能下降无关。

研究设计与样本

  • 研究纳入德国糖尿病研究中病程<1年的1型糖尿病165例和2型糖尿病291例。
  • 采用邻近延伸分析技术检测基线74种生物标志物血清浓度。
  • 使用多元线性回归和逻辑回归分析生物标志物与eGFR及5年肾功能下降的关联。

主要发现

  • 1型糖尿病基线eGFR高于2型糖尿病(102 ± 15 vs 90 ± 16 mL/min/1.73 m2;P < 0.0001)。
  • 充分校正协变量及多重检验后,1型糖尿病中7种生物标志物与较低基线eGFR相关,2型糖尿病中24种相关。
  • 6种生物标志物(CD5、CCL23、CST5、IL-10RB、PD-L1、TNFRSF9)在两种糖尿病中均与eGFR呈负相关。
  • 前瞻性分析未发现炎症生物标志物与肾功能下降的关联。
  • 未发现糖尿病类型与炎症生物标志物之间的交互作用证据。

关键数值与推荐

  • 1型糖尿病中7种、2型糖尿病中24种炎症生物标志物与较低基线eGFR相关。
  • 6种生物标志物(CD5、CCL23、CST5、IL-10RB、PD-L1、TNFRSF9)在两种糖尿病中均与eGFR负相关。

临床怎么用

  • 对于新发1型或2型糖尿病患者,可关注上述炎症生物标志物与基线肾功能的关系。
  • 炎症生物标志物可能不适用于预测诊断后5年内的肾功能下降。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: While inflammation has been associated with kidney function in long-standing diabetes, its possible association in newly diagnosed diabetes is unknown. OBJECTIVE: To investigate cross-sectional and prospective associations between biomarkers of inflammation and kidney function in recent-onset diabetes. METHODS: The study included individuals with type 1 and type 2 diabetes with known diabetes duration of <1 year from the German Diabetes Study. Baseline serum concentrations of 74 biomarkers were measured using proximity extension assay technology and their associations with estimated glomerular filtration rate (eGFR) and kidney function decline over 5 years were tested using multiple linear and logistic regression analysis. RESULTS: The cross-sectional analysis included 165 individuals with type 1 diabetes and 291 with type 2 diabetes. Baseline eGFR was higher in type 1 compared with type 2 diabetes (102 ± 15 vs 90 ± 16 mL/min/1.73 m2; P < 0.0001). After full adjustment for covariates and multiple testing, 7 biomarkers were associated with lower baseline eGFR in type 1 diabetes and 24 were associated with lower baseline eGFR in type 2 diabetes. Among these biomarkers, 6 biomarkers (CD5, CCL23, CST5, IL-10RB, PD-L1, TNFRSF9) were inversely associated with eGFR in both diabetes types. The prospective analysis did not detect associations between inflammatory biomarkers and kidney function decline. No evidence of an interaction between diabetes type and inflammatory biomarkers was found. CONCLUSION: Several biomarkers of inflammation associate with lower baseline eGFR in recent-onset type 1 and type 2 diabetes, but do not associate with kidney function loss during the first 5 years after the diagnosis of diabetes.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Maalmi H, Herder C, Strassburger K, et al. Biomarkers of Inflammation and Glomerular Filtration Rate in Individuals with Recent-Onset Type 1 and Type 2 Diabetes. J Clin Endocrinol Metab. 2020. PMID: 32879938. doi:10.1210/clinem/dgaa622

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。